Benzinga's Volume Movers

shares climbed 53.28 percent to $20.34. The volume of Aerie Pharmaceuticals shares traded was 1348 percent higher than normal. Aerie Pharmaceuticals jumped on news that regulators agreed to a new primary endpoint for its study of its proposed glaucoma treatment. Needham upgraded Aerie Pharmaceuticals from Hold to Buy.

surged 17.80 percent to $30.71. The volume of Coty shares traded 943 percent higher than normal. Coty has purchased P&G's beauty product lines for $12 billion and also has won an auction for P&G's hair-care unit, a source familiar with the matter told Reuters.

shares moved up 2.13 percent to $42.92. The volume of Inogen traded was 282 percent higher than normal. Inogen shares have jumped 113.89 percent over the past 52 weeks, while the S&P 500 index has surged 7.33 percent in the same period.

shares rose 2.95 percent to $23.67. The volume of Sagent Pharmaceuticals shares traded was 172 percent higher than normal. Sagent Pharmaceuticals' trailing-twelve-month revenue is $300.76 million.